Sarah Buchs

Sarah Buchs has a diverse work experience spanning over several companies. Sarah began their career in 2006 as a Freelancing Journalist at Thuner Tagblatt. In 2008, they worked as an Assistant at FASMED - Swiss Medical Device Industry and also served as a Student Assistant at Impulsa AG. In 2010, they were a Student Assistant at Panvica, Pension fund, where they gained basic experience in accounting and customer care.

Sarah joined Novo Nordisk in 2014, initially as a Health Economic Graduate, then as an HEOR Fellow, and later as a Global HEOR Manager in 2016. Sarah worked on health economic projects and supported the development of value communication tools.

In 2016, Sarah joined ALK as a Global Market Access Manager. Sarah developed market access strategies and health economic strategies for various products, including ALK's HDM tablet and tree tablet. In 2020, they were promoted to Senior Global Market Access Manager and is currently serving as the Director of Global Commercial Excellence starting from December 2022.

Overall, Sarah Buchs has a strong background in health economics, market access, and strategic management in the pharmaceutical industry.

Sarah Buchs obtained their Master of Science (M.Sc.) degree in Economics from the University of Bern, where they studied from 2006 to 2013. In 2011, they also had an exchange term in Economics at Københavns Universitet - University of Copenhagen.